Medical Device Regulations and Regulators Flashcards
What are medical maggots used for, and what is the confused with how they are defined?
Medical maggots are used for cleaning wounds. The USA defines them as medical devices, however in Europe they are categorised as a medicine.
Why is there the differences in the way that medical maggots are defined?
The reason the USA state medical maggots as a medical device is because they argue that the maggots use their teeth to clean the wound, therefore it has a mechanical function. In Europe, they argue that the maggots release a chemical, and its the chemical reaction that cleans the wound, therefore it would be a medicine.
What is the definition of a medical device, as stated by the TGA?
The TGA states that a medical device is:
‘An instrument, apparatus, appliance, material or other article intended to be used on human beings for:
-Diagnosis, prevention, monitoring, treatment or alleviation of disease, injury or disability
-Investigation, replacement or modification of the anatomy or a physiological process
-Control of conception
What does IVD in diagnostics stand for?
In Vitro Diagnostics
Give an example of an IVD.
A glucose monitor.
What are the four categories for classifying medical devices, and give examples in each category?
- Class I: lowest risk; gloves, wheel chair, spectacles etc
- Class IIa: contact lenses, catheters
- Class IIb: condoms, blood bags
- Class III: highest risk; heart valves.
How does the level of regulatory control compare to the product risk class?
If the product risk class is high, then the level of regulatory control will be high. Vice versa.
How are medical implants classified?
They are a subset of medical devices.
Give some examples of medical implants?
Spinal implants, knee joints, bone screws, shoulder joints, heart valve, stents
What is the difference between a medical device and a medical implant?
An implant goes inside the human body.
Following a number of implant scandals involving metal-on-metal hips, breast implants, and mesh implants, what did the House of Commons do?
The House of Commons select committee held an evidence session on Regulation of Medical Implants in the EU and UK, and produced a report on this in Nov 2012.
What was the response from the government to the report written by the House of Commons?
The government responded by saying that despite there being issues with the existing system, it has still done some great things and there is no need for any change.
What issue did Jeremy Hunt raise with the European regulator?
In October 2012, Jeremy Hunt spoke out about a regulator in the EU that said it was on the side of the manufacturer, despite being a notified body.
Why was it concerning that the notified body sided with the manufacturer?
Because the notified body was suppose to remain independent when licencing, however they were trying to make a profit by helping the manufacturer.
What changes have happened recently with the EU legislation?
It has increased in volume substantially. It took a 7 year journey as all EU countries had to agree to it.
What is the new EU Legislation called?
EU MDR 2017/745
How long is the transition period for the new EU Legislation?
3 years, so it should come into affect in may 2020
What was the previous EU legislation called?
Medical Devices Directive (93/42/EEC) it was made in 1993
What is the scepticism with the new EU regulations?
- Lack of transparency
- The notified bodies are still commercial interests
- No clinical investigations required if implant is substantially equivalent
What is the issue with the lack of transparency with the new EU regulations?
Members of the public cannot see the documents made by the notified bodies to decide if a company can go ahead. This is however the law because the information can be commercially sensitive, and they wouldn’t want any competitors gaining any knowledge.
What is substantial equivalence?
It is when one product is substantially equivalent to another product, so no clinical investigations are required.
What must be included in the post-market surveillance as stated by the new MDR?
It must include:
- Information on serious incidents
- Relevant literature on registries
- Complaints must be recognised and dealt with
- Information about similar medical devices
- They must be proactive and systematic
- Effective and appropriate methods and processes to access the collected data
- Suitable indicators and threshold values that shall be used in the continuous reassessment of the benefit-risk analysis and of the Risk Assessment.
- Effective tools to trace and identify devices for which corrective actions might be necessary
What is post-market surveillance?
Post Market Surveillance is the systematic
-collection
-analysis
-interpretation
-review
of product related data to ensure distributed products meet specified performance and safety requirements .
What are the purchasing controls on post market surveillance?
- defined component and service specifications
- defined quality requirements for suppliers
- suppliers are qualified and monitored